Evaluating the safety of TDF, an HIV drug, for pregnant women facing COVID-19
Among pregnant women who use the HIV drug tenofovir disoproxil fumarate, there was no greater risk of malformations in their newborns than from other antiretroviral therapies, according to new research from Harvard Chan School.
Worldwide Week highlights Harvard’s global reach
Harvard Worldwide Week 2020 showcases the breadth of the University’s global engagement through a host of virtual offerings and features a host of Harvard Chan School experts.
